Crystal Lennie appointed to Canadian Institutes of Health Research - CBC
This story deserves to be shared
Send it to someone who'd care, or post it on your networks.
Skip to Main ContentAccessibility HelpMenuCBC GemCBC ListenSearchQuick LinksNewsSportsRadioMusicListen LiveTVWatchradioTop StoriesShowsPodcastsSchedulesFrequencyListen LiveVideoCrystal Lennie appointed to Canadian Institutes of Health Research | CBC.ca LoadedThe Trailbreaker7:30Crystal Lennie appointed to Canadian Institutes of Health ResearchOctober 6RadioDuration 7:30Inuvik resident Crystal Lennie is a new appointee to the governing council of the Canadian Institutes of Health Research. She spoke to the CBC’s Marc Winkler about her new appointment and journey up to this point. More from RadioVideoDuration 1:18‘She’s trying to change the culture of Cornell,’ says Jane Doe’s lawyerOctober 14VideoDuration 1:04Jane Doe’s home was swatted, says lawyer in Cornell gang-rape caseOctober 14VideoDuration 1:40How menopause shook Olympian Clara HughesOctober 12VideoDuration 1:53Will Carney's plan to 'Build Canada Strong' hurt the environment?
This article is an excerpt. To read the full content, visit the original source. CBC
Related articles
Continuous glucose monitors help type 2 diabetes patients spend 5 more hours a day in healthy blood sugar range - Medical Xpress
Continuous glucose monitors (CGMs) could transform diabetes management for millions of Americans with type 2 diabetes who don't take insulin, according to findings published in the New England Journal of Medicine. The clinical trial found that adults using CGMs spent approximately five additional hours each day within their target blood sugar range compared with those receiving routine care. Nearly twice as many CGM users also achieved an A1c level below 7%, a common treatment goal for people with diabetes.
Wearing headphones during surgery may reduce nausea and vomiting afterward - Medical Xpress
Patients who wore noise-canceling headphones during minimally invasive gynecological surgery were significantly less likely to experience postoperative nausea and vomiting (PONV), suggest findings from a randomized clinical trial presented at the Anesthesiology 2026 annual meeting.
Kefah Mokbel: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? - Oncodaily
“Beyond Detecting Cancer Recurrence: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? An exciting new study published in The Oncologist highlights the clinical potential of Signatera Genome, a whole-genome sequencing (WGS)-based, tumor-informed circulating tumor DNA (ctDNA) assay, not only for detecting molecular residual disease (MRD), but also for potentially informing adjuvant treatment decisions.
0 comments
No comments yet. Be the first to share your thoughts!